Literature DB >> 5488382

Single-dose therapy with streptomycin and sulfametopyrazine for bacteriuria during pregnancy.

J D Williams, E K Smith.   

Abstract

One hundred and sixty-three patients with bacteriuria in pregnancy were treated with a single dose of antibiotic. Four regimens were used: sulfadoxine (sulphormethoxine) 2 g., sulfametopyrazine 2 g., streptomycin 1 g., and a combination of sulfametopyrazine 2 g. and streptomycin 1 g. The highest cure rate of 77% was achieved with streptomycin and sulfametopyrazine. The long-acting sulphonamides alone gave a cure rate of 55% while streptomycin alone eradicated 43% of the infections. Despite the high cure rate with combined therapy bacterial resistance developed in some cases.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5488382      PMCID: PMC1820266          DOI: 10.1136/bmj.4.5736.651

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  ERADICATION OF BACTERIURIA IN PREGNANCY BY A SHORT COURSE OF CHEMOTHERAPY.

Authors:  J D WILLIAMS; W BRUMFITT; D LEIGH; A PERCIVAL
Journal:  Lancet       Date:  1965-04-17       Impact factor: 79.321

2.  STREPTOMYCIN IN PREGNANCY: EFFECT ON THE FOETAL EAR.

Authors:  N CONWAY; B D BIRT
Journal:  Br Med J       Date:  1965-07-31

3.  The dissociation of bilirubin from albumin and its clinical implications.

Authors:  G B ODELL
Journal:  J Pediatr       Date:  1959-09       Impact factor: 4.406

4.  THE POSSIBLE RELATIONSHIP BETWEEN THE MATERNAL ADMINISTRATION OF SULPHAMETHOXYPYRIDAZINE AND HYPERBILIRUBINAEMIA IN THE NEWBORN.

Authors:  P M DUNN
Journal:  J Obstet Gynaecol Br Commonw       Date:  1964-02

5.  THE ABSORPTION, DISTRIBUTION, AND EXCRETION OF STREPTOMYCIN IN MAN.

Authors:  C W Buggs; M A Pilling; B Bronstein; J W Hirshfeld; L Worzniak; L J Key
Journal:  J Clin Invest       Date:  1946-01       Impact factor: 14.808

Review 6.  Bacteriuria of pregnancy.

Authors:  P Whalley
Journal:  Am J Obstet Gynecol       Date:  1967-03-01       Impact factor: 8.661

Review 7.  The effects of pharmacologic agents upon the fetus and newborn.

Authors:  K Adamsons; I Joelsson
Journal:  Am J Obstet Gynecol       Date:  1966-10-01       Impact factor: 8.661

8.  Single-dose treatment of acute urinary tract infection: a controlled trial.

Authors:  R N Grüneberg; W Brumfitt
Journal:  Br Med J       Date:  1967-09-09
  8 in total
  9 in total

1.  Treatment of urinary infections in pregnancy using single versus 10-day dosing.

Authors:  M D Adelson; W L Graves; N G Osborne
Journal:  J Natl Med Assoc       Date:  1992-01       Impact factor: 1.798

2.  Single-dose antibiotic treatment: a new approach to lower urinary tract infections in primary care.

Authors:  S Shortt
Journal:  Can Fam Physician       Date:  1981-01       Impact factor: 3.275

Review 3.  Management of urinary tract infections in pregnancy: a review with comments on single dose therapy.

Authors:  S H Zinner
Journal:  Infection       Date:  1992       Impact factor: 3.553

4.  Single dose antibacterial treatment for uncomplicated UTIs.

Authors:  R R Bailey
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

5.  Single-dose antibacterial treatment for bacteriuria in pregnancy.

Authors:  R R Bailey
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

6.  Single-dose cefonicid therapy for urinary tract infections.

Authors:  R E Pontzer; R E Krieger; J A Boscia; W McNamee; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

7.  A general practitioner multicenter study: fosfomycin trometamol single dose versus pipemidic acid multiple dose.

Authors:  A Jardin
Journal:  Infection       Date:  1990       Impact factor: 3.553

Review 8.  Review of published studies on single dose therapy of urinary tract infections.

Authors:  R R Bailey
Journal:  Infection       Date:  1990       Impact factor: 3.553

9.  Single-dose/short-term therapy in children and in pregnant women.

Authors:  R R Bailey
Journal:  Infection       Date:  1994       Impact factor: 3.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.